Stella Diagnostics Inc.
SLDXOTCHealthcare● Active
$0.02
+$0.01(+60.71%)
Market Cap$2194891
P/E Ratio—
52W High$0.05195
52W Low$0.0111
Stella Diagnostics Inc. (SLDX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SLDX · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.78M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $2.44M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | ($0.66M) | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | -37.02% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.25M | $0.60M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $2.79M | $1.01M | $11.43M | $2.45M | $4.74M |
| Operating Income | ($3.45M) | ($1.01M) | ($11.43M) | ($2.45M) | ($4.74M) |
| Operating Margin %(computed) | -193.24% | — | — | — | — |
| Interest Income | $0.00M | $0.03M | $0.15M | $0.00M | $0.00M |
| Interest Expense | $0.61M | $0.00M | $0.00M | $0.31M | $0.30M |
| Income Before Tax | ($4.06M) | ($1.24M) | ($5.71M) | ($5.64M) | ($16.64M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($4.06M) | ($1.24M) | ($5.71M) | ($5.64M) | ($16.64M) |
| Net Margin %(computed) | -227.47% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-0.00 | $-0.02 | $-0.03 | $-0.17 |
| Wtd Avg Shares | 345.97M | 401.60M | 299.99M | 165.12M | 96.37M |
| EBITDA | ($3.45M) | ($1.24M) | ($5.54M) | ($5.10M) | ($16.10M) |
| EBITDA Margin %(computed) | -193.24% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Stella Diagnostics Inc. data
About Stella Diagnostics Inc. (SLDX) Income Statement
Stella Diagnostics Inc. (SLDX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, SLDX reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -37.02%), and net income of ($0.00B) — a net profit margin of -227.47%.
Frequently asked questions
SLDX · 4 questionsStella Diagnostics Inc. (SLDX) reported revenue of $0.00B for 2025, up —% year-over-year.
SLDX revenueSLDX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09